MedTrace Logo

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

NCT00927641 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2015-06-04

No results posted yet for this study

Summary

The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.

Conditions

  • Ankle Sprain

Interventions

DRUG

Ketoprofen Patch

Two Ketoprofen HKT-500 patches applied to target ankle once daily for 14 days

OTHER

Placebo Patch

Two placebo patches placed on target ankle once daily for 14 days

Sponsors & Collaborators

  • Hisamitsu Pharmaceutical Co., Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927641 on ClinicalTrials.gov